QIAGEN and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreements

QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) and OncXerna Therapeutics, Inc. ("OncXerna”),...